Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Jefferies

Missed the AI Rally? Jefferies Says CrowdStrike and These 3 Other Cybersecurity Stocks Could Be Next

Cybersecurity stocks have trailed the tech rally, but Jefferies sees 2026 as the year market leaders begin to separate from the pack.

Barchart

Should You Buy the Dip in First Solar Stock?

First Solar stock sinks as Jefferies downgrade it to “hold”. Here’s why the investment firm cautions against owning FSLR shares at current levels.

Barchart

Reddit Buy Alert: Could It Really Have 40% Upside Potential?

Reddit is continuing to attract bullish analyst calls, with some of the more recent updates calling for additional upside of 40% from current levels.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Jefferies Is Betting Big on Mining Stocks for 2026. Here Is Barchart’s Top-Rated Name.

This gold miner stock's strong fundamentals put it at the top of the list.

Barchart

As Mortgage Rates Remain High, This 1 Stock Has Been a Big Winner in 2025

While mortgage rates remain high, Rocket Companies has outperformed its peers this year.

Barchart

Dear D-Wave Quantum Computing Fans, Mark Your Calendars for January 7

D-Wave stock soared Monday after management announced plans of participating in the CES 2026. Jefferies sees QBTS shares hitting $45 in the coming year.

Barchart

Morgan Stanley Sees a Sweet Turnaround Play in This 1 Stock. Should You Buy Shares Here?

Morgan Stanley expects a recovery and sees upside for Hershey. Should you buy into the stock now?

Barchart

Read news from The Economist, FT, and more,
with one subscription

1 Analyst Is Betting on 73% Upside Potential for D-Wave Quantum Stock. Should You Buy QBTS Shares Here?

Jefferies just set a $45 price target on QBTS.

Barchart

Wall Street Loves This Software Stock for 2026. Should You Buy It Now?

Wall Street sees Okta as an AI identity winner for 2026, though rich multiples leave little margin for growth slowdowns.

Barchart

IonQ Just Got a New Street-High Price Target. What Is the Bull Case for Quantum Computing Stocks in 2026?

Jefferies just set a $100 price target on IonQ.

Barchart

Jefferies Says IonQ Stock Can Double Over the Next 12 Months. Should You Buy It Here?

Down almost 50% from all-time highs, IonQ is a quantum computing stock with significant upside potential, according to investment firm Jefferies.

Barchart

Analysts Say This 1 Lesser-Known Chip Stock Is a Top Buy for 2026. Should You Add It to Your Portfolios Here?

KLAC stock is gaining momentum after Jefferies grouped it with Nvidia and Broadcom as one of the best semiconductor buys for 2026.

Barchart

Quantum computing could be a $198 billion industry in the next 15 years, Jefferies analyst says

The downside is that the physics and engineering needed to make quantum computers work have only just moved out of the theoretical realm and into reality.

Fortune

FTSE 100 makes headway ahead of likely Bank of England rate cut

The FTSE 100 index closed up 102.28 points, 1.1%, at 9,751.31.

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

As Baidu Spins Off Its AI Chip Division, Should You Buy, Sell, or Hold BIDU Stock?

Baidu’s AI ambitions are accelerating, but a chip spinoff adds both upside potential and execution risk.

Barchart

Humana Stock Is Nearly 20% Off Its YTD Highs. Can Mark Cuban Change That?

Mark Cuban is allegedly looking to partner with Humana on pharmacy offerings.

Benzinga

Mastercard To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Wedbush Says It’s Time to ‘Take Advantage’ and Buy the Dip in This 1 Former Meme Stock

Wedbush’s latest bullish call suggests Carvana’s pullback may be an opportunity for investors.

Evening Standard

Buoyant miners fail to fire lacklustre FTSE 100

Miners led the way in London on rising metals prices, with copper showing particular strength.

Benzinga

SEC Opens Civil Probe Into Jefferies Over $12B First Brands Collapse

The U.S. Securities and Exchange Commission is investigating Jefferies Financial Group Inc. (NYSE:JEF) over whether the investment bank adequately informed investors about its exposure to First Brands Group, the now-bankrupt car parts supplier whose collapse triggered widespread scrutiny across the private credit sector.

Barchart

A $4 Billion Reason to Buy Nokia Stock Now

Nokia has agreed to invest $4 billion in U.S. R&D and manufacturing.

Benzinga

Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Best Buy Q3 Earnings: 'Hidden' Ad Revenue, Hardware Margin Squeeze And More— What Should Investors Expect This Time?

As Best Buy Co. Inc. (NYSE:BBY) prepares to report third-quarter fiscal 2026 earnings on Nov. 25, the retailer faces a critical test that goes beyond simple sales figures: can a high-margin, “hidden” advertising business counterbalance the profitability pressure of selling lower-margin hardware?

Benzinga

Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Monday released topline results from its randomized controlled clinical study (VP-VLY-686-2601) evaluating tradipitant to prevent nausea and vomiting induced by Novo Nordisk A/S (NYSE:NVO) Wegovy.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.